Investor Relations News: Breaking Investor Relations News, Comments and Articles. - Page: 3

Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise™ DBS System In Treatment Of Parkinson's Disease

NATICK, Mass., June 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the first implantation of its Vercise™ DBS System as part of the INTREPID clinical trial.  INTREPID is a prospective, multi-center, double-blinded, randomized, controlled study to evaluate the safety and effectiveness of motor function and overall quality of life in patients with the Ve...

Amicus Therapeutics' CEO Presents at Fabry Monotherapy Strategic Update Conference (Transcript)

Amicus Therapeutics, Inc. (FOLD) Fabry Monotherapy Strategic Update Conference Call June 17, 2013 8:00 am ET Executives Sara Pellegrino – Investor Relations John F. Crowley – Chairman and Chief Executive Officer William D. Baird – Chief Financial Officer Analysts Ritu Baral – Canaccord Adams Edward Nash – Cowen and Company Anupam Rama – JPMorgan Kim Lee – Janney Capital Josep...

Mt. Washington Pediatric Hospital Named A "Top 100 Great Place To Work In Healthcare"

BALTIMORE, June 17, 2013 /PRNewswire-USNewswire/ -- What is it like to be named one of the Top 100 Great Places to Work in Healthcare? Well, it's quite an honor. Just ask Mt. Washington Pediatric Hospital (MWPH). The 102-bed Baltimore hospital was recently ranked among the best of the best by Becker's Hospital Review, a periodical featuring business and analysis relating to hospitals and heal...

Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America

ST. PAUL, Minn., June 17, 2013 /PRNewswire/ -- Prime Therapeutics, in collaboration with public relations agency, Weber Shandwick, and branding and design agency, Larsen, was awarded the Silver Anvil for its internal communication campaign "Millions of Reasons, One Purpose, Repositioning Prime Therapeutics." The award was presented at the Public Relations Society of America (PRSA) 2013 Silver Anvi...

Durata Looks Beyond FDA: Reimbursement Changes May Offer Opening for Long-Acting Anti-infective

Is the FDA regulatory climate getting better for anti-infective development? One clear “yes” emerges from the approach being taken by Durata Therapeutics in a series of recent investor presentations: Durata is focusing beyond FDA on the next chal...

Waters Corporation Presentation at the Wells Fargo Securities 2013 Healthcare Conference to Be Audio Webcast Live

Waters Corporation (NYSE:WAT) John Ornell, Chief Financial Officer, will speak to the investment community at the Wells Fargo Securities 2013 Healthcare Conference at the InterContinental Boston Hotel on Tuesday, June 18th at 11:10 a.m. eastern time. Interested investors can access the live audio webcast of the presentation by logging on to Waters...

UPDATE 1-Rhoen investor row could drag on until 2015, lawyer says

* Lawyer says dispute could be with federal court in 18 mths

New drug proving effective in attacking advanced prostate cancer

INDIANAPOLIS, June 17, 2013 /PRNewswire-USNewswire/ -- Franciscan St. Francis Health Cancer Center today (June 17) is the first medical facility in Indiana to use a new drug to treat men with advanced prostate cancer. It's called Xofigo®, a radiopharmaceutical used in patients with late-stage, metastatic disease that has spread to the bones. It recently was approved for use by the U.S. Food...

Rhoen lawyer says investor row could drag on until 2015

FRANKFURT, June 17 (Reuters) - A lawyer representing Rhoen-Klinikum's Chairman Eugen Muench said the looming legal battle with a dissenting shareholder over the hospital chain's deal strategy could drag on for well over 18 months, delaying a possible...

MdBio Foundation Names New Board Members

Executives from BroadOak Capital Partners, Cardiocore and Emergent BioSolutions Join 15 Member Board The MdBio Foundation today announced the addition of three new members to its board of directors. The new members include Jennifer Cotteleer, president of Cardiocore; Allen (Al) Shofe, executive vice president of corporate affairs at Emergent Bio...

Harbor-UCLA Medical Center Awards Black Diamond Video Contract for OR Video Integration

Black Diamond Video (BDV) announced that Harbor-UCLA Medical Center selected Black Diamond Video to provide operating room audio video integration for their new Surgery/Emergency Replacement Project. Black Diamond Video will install the Integrated Digital Surgical Suite (IDSS), an all-digital, high resolution video routing and display solution, in...

MicroAgility, Inc. Celebrates Its 10th Anniversary with Gratitude

New York, NY, June 17, 2013 --(PR.com)-- MicroAgility, Inc, an award-winning business and technology consulting company, announced today that it will be commemorating the 10th anniversary of its founding in 2003 with utmost gratitude. “MicroAgility is celebrating ten years of dedication, accomplishment, and partnership with our clients, employees, and partners,” said Sajid Khan, Pres...

Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody Drug Conjugate Combining HuMax-TAC and PBD Warhead.

      Antibody-drug conjugate (ADC) to be developed for cancer Combines strength of HuMax®-TAC with next generation PBD-based warhead technology 50:50 partnership Copenhagen, Denmark and Lausanne, Switzerland; 17 June 2013 – Genmab A/S (OMX: GEN) and ADC Therapeutics, announced today an agreement to develop a new antibody-drug conjugate (ADC) product comb...

Medbox Issues Status Update to Company Shareholders

HOLLYWOOD, Calif., June 17, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, issued a status update to its shareholders on past, present, and future projects. The following is a summary of key events and projects in recent weeks: Medbox received its first round of...

Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago

MUNDELEIN, Ill., June 17, 2013 /PRNewswire/ -- Z Trim Holdings, Inc. (OTC Markets: ZTHO – News), a biotechnology company providing value-added ingredients to a variety of industries, today announced that it will be presenting a new meat application at this year's annual Institute of Food Technologists (IFT) show in Chicago, July 13-16.   The Company will demonstrate how Z Trim ingr...

Funding For 'Holy Grail' Of Anticoagulant Drugs, University Of Cambridge

XO1 Ltd, a University of Cambridge and Addenbrooke's Hospital spin-out company, has raised $11 million in funding to develop a new anticoagulant medication which prevents stroke and heart attacks without causing bleeding. The company explained that t...

A Big "LIKE" for Oral Hygiene

TEL AVIV, Israel, June 17, 2013 /PRNewswire/ -- Breezy, a portfolio company of The Trendlines Group, launched their first product this week using a platform technology enabling innovative treatment of mouth-cavity conditions. LIKE, a confectionary-based product which combats halitosis (bad breath) is being sold in major Israeli pharmacy chains and will reach a distribution of 650 stores. This com...

Three Scientists to Receive Prestigious Novartis Prizes for Immunology at 15th International Congress of Immunology

Novartis International AG / Three Scientists to Receive Prestigious Novartis Prizes for Immunology at 15th International Congress of Immunology . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. The Basic Immunology Prize is awarded to Drs. Tim R. Mossman and Robert L. Coffman for their work in defining subsets of T helper...

MedeAnalytics Introduces New Financial Strategy Analytics Solution for Hospitals and Health Systems at HFMA 2013 Annual National Institute

ORLANDO, Fla., June 17, 2013 /PRNewswire/ -- Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Financial Strategy Analytics solution, a powerful tool that enables hospitals and health systems to proactively manage finances, hone strategic planning, and optimize managed care performance metrics in the context of today's rapidly cha...

Settlement Reached in Wright Profemur Hip Lawsuit: Now, AttorneyOne Can Provide Advice

According to a court order issued on March 20, a settlement has been reached in a Wright Profemur hip lawsuit alleging that the implant failed. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Wright Hip Implant serious complications. San Diego, CA (PR...

PAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 26, 2013

BOSTON, June 17, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on Wednesday, June 26, 2013, from 8:30 a.m. to 12:30 p.m. (EDT). All interested parties are invited to listen as Chairman and Chief Executive Officer Josef von Rickenbach, Chief Fi...

The Dental Care Group Retains TransMedia Group to Publicize How Its Oral DNA Testing, and Services Supporting Stem Cell Research are Improving The Lives of Its Patients

AVENTURA, Fla., June 17, 2013 /PRNewswire/ -- The Dental Care Group (www.dentalcaregroup.net/) has retained TransMedia Group to publicize how its oral DNA testing provides patients with insights into their genetic susceptibility to certain diseases. TransMedia Group will highlight how this genetic testing can help improve patients' lives.  The firm said its publicity will show...

Broader spectrum

Ebb & Flow Broader spectrum Prism Pharma Co. Ltd. plans to use the $15 million it raised in a series C round last week to expand the Japanese company's focus beyond cancer and beef up its valuation. New investor …

Aehr Test Systems to Participate in the Fifth Annual CEO Investor Summit 2013

FREMONT, Calif., June 17, 2013 (GLOBE NEWSWIRE) -- Aehr Test Systems (Nasdaq:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that Gayn Erickson, President and CEO, will present at the Fifth Annual CEO Investor Summit 2013, Wednesday, July 10, 2013 in San Francisco, California. About The Fifth Annual CEO Summit The CEO Summit is an accredited investor a...

Ventrus Biosciences, Inc. Investor Alert: Scott+Scott, Attorneys at Law, LLP Notifies Investors of Upcoming Deadline in Ventrus Class Action Lawsuit -- VTUS

NEW YORK, June 17, 2013 (GLOBE NEWSWIRE) -- On May 9, 2013, Scott+Scott, Attorneys at Law, LLP filed the first class action complaint against Ventrus Biosciences, Inc. ("Ventrus" or the "Company") on behalf of the putative class of investors who purchased or otherwise acquired Ventrus common stock (Nasdaq:VTUS) between December 17, 2010 and June 25, 2012, inclusive (the "Class Period"). The secur...